Cite

HARVARD Citation

    Gerstein, H. et al. (2019). Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. Lancet. 394 (10193), pp. 131-138. [Online]. 
  
Back to record